Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 2 (2005), Issue 2 (February)

1. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.
   Radiother Oncol, 74(1): 67-9. [Abstract] [Full-text]
2. Repositioning accuracy of fractionated stereotactic irradiation: assessment of isocentre alignment for different dental fixations by using sequential CT scanning.
   Radiother Oncol, 74(1): 61-6. [Abstract] [Full-text]
3. Treatment accuracy of fractionated stereotactic radiotherapy.
   Radiother Oncol, 74(1): 53-9. [Abstract] [Full-text]
4. Tomotherapy planning of small brain tumours.
   Radiother Oncol, 74(1): 49-52. [Abstract] [Full-text]
5. High precision conformal radiotherapy employing conservative margins in childhood benign and low-grade brain tumours.
   Radiother Oncol, 74(1): 37-44. [Abstract] [Full-text]
6. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
   J Cell Physiol, 203(1): 127-32. [Abstract] [Full-text]
7. Organs from donors with primary brain malignancy: the fate of cardiac allograft recipients.
   Transplant Proc, 36(10): 3133-7. [Abstract] [Full-text]
8. Brain death due to supratentorial masses: diagnosis using transcranial Doppler sonography.
   Transplant Proc, 36(10): 2898-900. [Abstract] [Full-text]
9. Effect of intravascular-to-extravascular water exchange on the determination of blood-to-tissue transfer constant by magnetic resonance imaging.
   Magn Reson Med, 53(2): 282-93. [Abstract] [Full-text]
10. Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma.
    Magn Reson Med, 53(1): 85-92. [Abstract] [Full-text]
11. Proton-decoupled 31P MRS in untreated pediatric brain tumors.
    Magn Reson Med, 53(1): 22-9. [Abstract] [Full-text]
12. Rosette-forming glioneuronal tumour of the fourth ventricle: report of a case with clinical and surgical implications.
    J Neurooncol, 71(2): 195-7. [Abstract] [Full-text]
13. Intraventricular tanycytic ependymoma: case report and review of the literature.
    J Neurooncol, 71(2): 189-93. [Abstract] [Full-text]
14. A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors.
    J Neurooncol, 71(2): 181-7. [Abstract] [Full-text]
15. A case of pleomorphic xanthoastrocytoma presenting with massive tumoral hemorrhage.
    J Neurooncol, 71(2): 169-71. [Abstract] [Full-text]
16. Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.
    J Neurooncol, 71(2): 161-8. [Abstract] [Full-text]
17. Long survival in an untreated solitary choroid plexus metastasis from renal cell carcinoma: case report and review of the literature.
    J Neurooncol, 71(2): 157-60. [Abstract] [Full-text]
18. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
    J Neurooncol, 71(2): 113-9. [Abstract] [Full-text]
19. Ganglioside GM3 inhibits proliferation and invasion of glioma.
    J Neurooncol, 71(2): 99-106. [Abstract] [Full-text]
20. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
    Oncogene, 24(6): 980-91. [Abstract] [Full-text]
21. Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.
    Cancer Immunol Immunother, 54(4): 372-82. [Abstract] [Full-text]
22. Intraoperative tumor segmentation and volume measurement in MRI-guided glioma surgery for tumor resection rate control.
    Acad Radiol, 12(1): 116-22. [Abstract] [Full-text]
23. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Acad Radiol, 12(1): 51-7. [Abstract] [Full-text]
24. Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats.
    Cancer Immunol Immunother, 54(4): 337-44. [Abstract] [Full-text]
25. Brain stem glioma: two case studies.
    J Pediatr Oncol Nurs, 22(2): 114-8. [Abstract] [Full-text]
26. VH gene analysis of primary CNS lymphomas.
    J Neurol Sci, 228(2): 143-7. [Abstract] [Full-text]
27. Proton MRS of the peritumoral brain.
    J Neurol Sci, 228(2): 137-42. [Abstract] [Full-text]
28. Time-lapse analysis of potential cellular responsiveness to Johrei, a Japanese healing technique.
    BMC Complement Altern Med, 5(1): 2. [Abstract] [Full-text]
29. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    J Biol Chem, 280(5): 3483-92. [Abstract] [Full-text]
30. Adaptation of skull clamp for use in image-guided surgery of children in the first 2 years of life.
    Childs Nerv Syst, 21(2): 148-9. [Abstract] [Full-text]
31. Childhood choroid plexus papillomas: operative complications.
    Childs Nerv Syst, 21(2): 138-43. [Abstract] [Full-text]
32. Pediatric embryonal tumor with epithelial immunophenotype showing absence of hSNF5/INI1 expression.
    Childs Nerv Syst, 21(2): 150-5. [Abstract] [Full-text]
33. Supratentorial malignant ependymoma in childhood: 16 years without relapse after hemispherectomy.
    Childs Nerv Syst, 21(2): 156-60. [Abstract] [Full-text]
34. Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.
    Eur J Surg Oncol, 31(2): 183-90. [Abstract] [Full-text]
35. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
    Neuroradiology, 47(1): 18-26. [Abstract] [Full-text]
36. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.
    J Clin Endocrinol Metab, 90(2): 800-4. [Abstract] [Full-text]
37. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation.
    J Clin Endocrinol Metab, 90(2): 689-94. [Abstract] [Full-text]
38. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis.
    Growth Horm IGF Res, 15(1): 28-32. [Abstract] [Full-text]
39. Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: case study.
    Neuro-oncol, 7(1): 97-100. [Abstract] [Full-text]
40. Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study.
    Neuro-oncol, 7(1): 90-6. [Abstract] [Full-text]
41. Well-differentiated neurocytoma: what is the best available treatment?
    Neuro-oncol, 7(1): 77-83. [Abstract] [Full-text]
42. Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.
    Neuro-oncol, 7(1): 49-63. [Abstract] [Full-text]
43. Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma.
    Neuro-oncol, 7(1): 41-8. [Abstract] [Full-text]
44. Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.
    Neuro-oncol, 7(1): 32-40. [Abstract] [Full-text]
45. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
    Neuro-oncol, 7(1): 20-31. [Abstract] [Full-text]
46. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
    Br J Cancer, 92(2): 359-65. [Abstract] [Full-text]
47. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Lab Invest, 85(2): 165-75. [Abstract] [Full-text]
48. Vessel size imaging using low intravascular contrast agent concentrations.
    MAGMA, 17(3): 313-6. [Abstract] [Full-text]
49. Multi-spin-echo J-resolved spectroscopic imaging without water suppression: application to a rat glioma at 7 T.
    MAGMA, 17(3): 140-8. [Abstract] [Full-text]
50. Characterization and detection of experimental rat gliomas using magnetic resonance imaging.
    MAGMA, 17(3): 133-9. [Abstract] [Full-text]
51. Genetic alteration of poly(ADP-ribose) polymerase-1 in human germ cell tumors.
    Jpn J Clin Oncol, 35(2): 97-102. [Abstract] [Full-text]
52. Epstein-Barr virus associated with primary CNS lymphoma and disseminated BCG infection in a child with AIDS.
    Int J Infect Dis, 9(2): 96-103. [Abstract] [Full-text]
53. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
    Int J Radiat Oncol Biol Phys, 61(3): 795-808. [Abstract] [Full-text]
54. Astrocytoma-like multiple sclerosis.
    Clin Neurol Neurosurg, 107(2): 152-7. [Abstract] [Full-text]
55. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery.
    Clin Neurol Neurosurg, 107(2): 108-12. [Abstract] [Full-text]
56. Level of evidence in the literature concerning brain tumor resection.
    Clin Neurol Neurosurg, 107(2): 95-8. [Abstract] [Full-text]
57. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.
    J Biol Chem, 280(7): 5870-4. [Abstract] [Full-text]
58. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
    Hum Pathol, 36(1): 36-43. [Abstract] [Full-text]
59. Differential role of hydrogen peroxide and staurosporine in induction of cell death in glioblastoma cells lacking DNA-dependent protein kinase.
    Apoptosis, 10(1): 185-92. [Abstract] [Full-text]
60. A system for brain tumor volume estimation via MR imaging and fuzzy connectedness.
    Comput Med Imaging Graph, 29(1): 21-34. [Abstract] [Full-text]
61. Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy.
    Cancer, 103(4): 869-73. [Abstract] [Full-text]
62. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
    Cancer, 103(4): 793-801. [Abstract] [Full-text]
63. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Cancer, 103(4): 802-9. [Abstract] [Full-text]
64. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
    Int J Cancer, 114(3): 380-6. [Abstract] [Full-text]
65. Biophysical measurement of brain tumor cohesion.
    Int J Cancer, 114(3): 371-9. [Abstract] [Full-text]
66. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
    Brain, 128: 678-87. [Abstract] [Full-text]
67. The role of poly (adenosine 5'-diphosphate-ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species.
    Endocrinology, 146(3): 1119-27. [Abstract] [Full-text]
68. Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain.
    Lab Invest, 85(3): 328-41. [Abstract] [Full-text]
69. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome.
    J Neurol Neurosurg Psychiatry, 76(3): 415-9. [Abstract] [Full-text]
70. Lower urinary tract function in patients with pituitary adenoma compressing hypothalamus.
    J Neurol Neurosurg Psychiatry, 76(3): 390-4. [Abstract] [Full-text]
71. Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies.
    Lab Invest, 85(3): 316-27. [Abstract] [Full-text]
72. Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.
    J Neurooncol, 71(1): 73-81. [Abstract] [Full-text]
73. Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature.
    J Neurooncol, 71(1): 67-72. [Abstract] [Full-text]
74. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
    J Neurooncol, 71(1): 61-5. [Abstract] [Full-text]
75. Cerebellar liponeurocytoma/lipidized medulloblastoma.
    J Neurooncol, 71(1): 53-9. [Abstract] [Full-text]
76. Isolated primary intracerebral mycetoma: presenting as a mass lesion in a patient with prostate cancer and multiple myeloma.
    J Neurooncol, 71(1): 49-52. [Abstract] [Full-text]
77. Brain metastasis in pediatric extracranial solid tumors: survey and literature review.
    J Neurooncol, 71(1): 43-8. [Abstract] [Full-text]
78. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
    J Neurooncol, 71(1): 33-8. [Abstract] [Full-text]
79. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
    J Neurooncol, 71(1): 3-7. [Abstract] [Full-text]
80. Selective excision of metastatic brain tumors originating in the motor cortex with preservation of function.
    J Clin Oncol, 23(6): 1209-17. [Abstract] [Full-text]
81. Liposome-mediated suicide gene therapy in humans.
    Methods Enzymol, 391: 200-8. [Abstract] [Full-text]
82. Capturing intraoperative deformations: research experience at Brigham and Women's Hospital.
    Med Image Anal, 9(2): 145-62. [Abstract] [Full-text]
83. Intraoperative facial motor evoked potential monitoring with transcranial electrical stimulation during skull base surgery.
    Clin Neurophysiol, 116(3): 588-96. [Abstract] [Full-text]
84. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Neoplasia, 7(1): 7-16. [Abstract] [Full-text]
85. Cortical laminar necrosis in childhood intracranial germ cell tumor survivors.
    Pediatr Blood Cancer, 44(4): 412-5. [Abstract] [Full-text]
86. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment.
    Pediatr Blood Cancer, 44(4): 363-9. [Abstract] [Full-text]
87. Intracranial germinoma: on whole-ventricular irradiation.
    Pediatr Blood Cancer, 44(4): 358-62. [Abstract] [Full-text]
88. Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child.
    Paediatr Anaesth, 15(3): 241-2. [Abstract] [Full-text]
89. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
    NMR Biomed, 18(1): 34-43. [Abstract] [Full-text]
90. The benefit of chemotherapy in a patient with multiple brain metastases and meningitis carcinomatosa from ovarian cancer.
    Int J Clin Oncol, 10(1): 69-71. [Abstract] [Full-text]
91. Long-term survival following concurrent chemoradiotherapy in patients with non-small-cell lung cancer with concomitant brain metastases only.
    Int J Clin Oncol, 10(1): 63-8. [Abstract] [Full-text]
92. Vessel size imaging in humans.
    Magn Reson Med, 53(3): 553-63. [Abstract] [Full-text]
93. Continuous arterial spin labeling using a train of adiabatic inversion pulses.
    J Magn Reson Imaging, 21(3): 290-6. [Abstract] [Full-text]
94. A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines.
    Proteomics, 5(3): 796-804. [Abstract] [Full-text]
95. Reproductive and hormonal factors and risk of brain tumors in adult females.
    Int J Cancer, 114(5): 797-805. [Abstract] [Full-text]
96. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro.
    Oncogene, 24(9): 1525-32. [Abstract] [Full-text]
97. Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas.
    J Neurooncol, 71(3): 325-32. [Abstract] [Full-text]
98. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
    J Neurooncol, 71(3): 319-23. [Abstract] [Full-text]
99. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.
    J Neurooncol, 71(3): 315-8. [Abstract] [Full-text]
100. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.
     J Neurooncol, 71(3): 307-13. [Abstract] [Full-text]
101. A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
     J Neurooncol, 71(3): 301-5. [Abstract] [Full-text]
102. UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.
     J Neurooncol, 71(3): 295-9. [Abstract] [Full-text]
103. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
     J Neurooncol, 71(3): 287-93. [Abstract] [Full-text]
104. Assessing perfusion changes during whole brain irradiation for patients with cerebral metastases.
     J Neurooncol, 71(3): 281-6. [Abstract] [Full-text]
105. Gefitinib ('Iressa', ZD1839) is active against brain metastases in a 77 year old patient.
     J Neurooncol, 71(3): 277-80. [Abstract] [Full-text]
106. Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study.
     J Neurooncol, 71(3): 271-6. [Abstract] [Full-text]
107. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
     J Neurooncol, 71(3): 259-65. [Abstract] [Full-text]
108. Up-regulation of neuropoiesis generating glial progenitors that infiltrate rat intracranial glioma.
     J Neurooncol, 71(3): 245-55. [Abstract] [Full-text]
109. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
     J Neurooncol, 71(3): 215-22. [Abstract] [Full-text]
110. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
     J Clin Pathol, 58(3): 263-8. [Abstract] [Full-text]
111. Pathobiology of brain metastases.
     J Clin Pathol, 58(3): 237-42. [Abstract] [Full-text]
112. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
     J Clin Oncol, 23(7): 1530-7. [Abstract] [Full-text]
113. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.
     J Clin Oncol, 23(7): 1507-13. [Abstract] [Full-text]
114. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
     Cancer Res, 65(4): 1136-40. [Abstract] [Full-text]
115. Meningeal melanocytoma of the posterior fossa: case report and literature review.
     Surg Neurol, 63(3): 269-73; discussion 273-4. [Abstract] [Full-text]
116. Long-term survival in a child with a brain stem dermoid cyst.
     Surg Neurol, 63(3): 261-3; discussion 263-4. [Abstract] [Full-text]
117. Diffusion-weighted EPI with magnetization transfer contrast.
     Magn Reson Imaging, 23(1): 35-9. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.